An interactive pharmacokinetic-pharmacodynamic model for patientspecific HIV treatment guidelines.

被引：0
|
作者：
Gajendran, V.
Kahn, J.
Mehta, M.
机构：
[1] Univ Calif Davis, Davis, CA 95616 USA
[2] Stanford Univ, Stanford, CA 94305 USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2007年 / 55卷 / 01期
关键词：
D O I：
10.1097/00042871-200701010-00428
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S145 / S145
页数：1
相关论文
共 50 条
  • [21] A Population Pharmacokinetic-Pharmacodynamic Model for Allopurinol in Patients with Gout
    Wright, Daniel F. B.
    Duffull, Stephen B.
    Merriman, Tony R.
    Barclay, Murray L.
    Stamp, Lisa K.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 : S33 - S33
  • [22] Atazanavir-bilirubin interaction: a pharmacokinetic-pharmacodynamic model
    Lozano, Roberto
    Domeque, Nieves
    Apesteguia, Alberto-Fermin
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2013, 5 : 153 - 159
  • [23] Longitudinal Pharmacokinetic-Pharmacodynamic Biomarkers Correlate With Treatment Outcome in Drug-Sensitive Pulmonary Tuberculosis: A Population Pharmacokinetic-Pharmacodynamic Analysis
    Kloprogge, Frank
    Mwandumba, Henry C.
    Banda, Gertrude
    Kamdolozi, Mercy
    Shani, Doris
    Corbett, Elizabeth L.
    Kontogianni, Nadia
    Ward, Steve
    Khoo, Saye H.
    Davies, Geraint R.
    Sloan, Derek J.
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (07):
  • [24] PHARMACOKINETIC-PHARMACODYNAMIC MODEL OF MAGNESIUM-SULFATE IN TREATMENT OF PREGNANCY-INDUCED HYPERTENSION
    CHEN, G
    LU, JF
    CAO, W
    ACTA PHARMACOLOGICA SINICA, 1991, 12 (03): : 222 - 225
  • [25] Evaluation of pharmacokinetics of warfarin from validated pharmacokinetic-pharmacodynamic model
    Sridharan, Kannan
    Al Banna, Rashed
    Husain, Aysha
    ADMET AND DMPK, 2021, 9 (02): : 143 - 149
  • [26] Guiding Dyslipidemia Treatment: A Population Pharmacokinetic-Pharmacodynamic Framework for Obicetrapib
    Dunn, Allison
    Ditmarsch, Marc
    Kastelein, John J. P.
    Kling, Douglas
    Neild, Annie
    Davidson, Michael H.
    Gobburu, Joga
    JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 64 (09): : 1150 - 1164
  • [27] Use of vancomycin pharmacokinetic-pharmacodynamic properties in the treatment of MRSA infections
    Giulano, Christopher
    Haase, Krystal K.
    Hall, Ronald
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2010, 8 (01) : 95 - 106
  • [28] A pharmacokinetic-pharmacodynamic model for intrathecal baclofen in patients with severe spasticity
    Heetla, H. W.
    Proost, J. H.
    Molmans, B. H.
    Staal, M. J.
    van Laar, T.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 81 (01) : 101 - 112
  • [29] A pharmacokinetic-pharmacodynamic model of acute tolerance to the subjective effects of alcohol
    Ramchandani, VA
    Hoefer, ME
    Edenberg, EF
    Walker, JT
    Hommer, DW
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2005, 29 (05) : 66A - 66A
  • [30] An Adaptation of the Eleveld Pharmacokinetic-Pharmacodynamic Model for a Burst Suppression Endpoint
    Lybbert, Carter
    Mickey, Brian J.
    Jones, Keith G.
    Odell, David
    Stanford, Jordan
    Tadler, Scott C.
    Huang, Jason
    Kuck, Kai
    ANESTHESIA AND ANALGESIA, 2023, 136 : 34 - 35
12345